MHE State of the Industry survey: COVID-19 ranks No.1
Respondents ranked the importance of healthcare issues.
MHE conducted our annual State of the Industry reader survey in October and November. Respondents were asked to rank the importance of healthcare issues and, no surprise, 71% of the rankings of COVID-19 by the respondents rated it as the number one healthcare issue. High drug prices were ranked as second most important healthcare issue by 29% of the respondents.
We also asked respondents to rank their level of agreement with a variety of statements about U.S. healthcare. Agreement was strongest (56%) with the statement, “The increasing enrollment in Medicare Advantage is a positive development,” and the strongest disagreement (62%) was with the statement, “Drug prices are high, but high prices mean investment in research and development.”
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
